Abstract
First described in organ transplant recipients in 1968, post-transplant lymphoproliferative disorder (PTLD) remains an often devastating complication of immunosuppression. Similar, if not identical, Epstein-Barr virus (EBV)- associated B lymphoproliferations have since been described in congenital and other acquired immunodeficiency states. Although PTLD is often morphologically indistinguishable from aggressive non-Hodgkin's lymphoma, the pathogenesis, presentation, clinical course, and management options differ significantly from those of classic NHL.
Original language | English (US) |
---|---|
Pages (from-to) | 963-973 |
Number of pages | 11 |
Journal | Hematology/Oncology Clinics of North America |
Volume | 11 |
Issue number | 5 |
DOIs | |
State | Published - Jan 1 1997 |
Externally published | Yes |
ASJC Scopus subject areas
- Hematology
- Oncology